Pingwei Xu

3.3k total citations
23 papers, 2.1k citations indexed

About

Pingwei Xu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Pingwei Xu has authored 23 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Pingwei Xu's work include Extracellular vesicles in disease (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (4 papers). Pingwei Xu is often cited by papers focused on Extracellular vesicles in disease (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (4 papers). Pingwei Xu collaborates with scholars based in China, United States and Canada. Pingwei Xu's co-authors include Ke Tang, Bo Huang, Jingwei Ma, Bo Huang, Huafeng Zhang, Huafeng Zhang, Foad Katirai, Dapeng Li, Yuying Liu and Duyun Ye and has published in prestigious journals such as Nature Communications, Nature Materials and The Journal of Immunology.

In The Last Decade

Pingwei Xu

23 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingwei Xu China 20 1.1k 618 511 451 366 23 2.1k
Jingwei Ma China 30 1.7k 1.5× 807 1.3× 1.1k 2.1× 466 1.0× 565 1.5× 63 3.1k
Simon Tazzyman United Kingdom 16 999 0.9× 478 0.8× 716 1.4× 358 0.8× 621 1.7× 25 2.2k
Hongwei Lv China 16 1.2k 1.1× 883 1.4× 281 0.5× 312 0.7× 332 0.9× 30 2.1k
Jing Song China 27 1.9k 1.7× 464 0.8× 350 0.7× 243 0.5× 671 1.8× 97 2.8k
Leni Moldovan United States 22 1.5k 1.3× 727 1.2× 402 0.8× 209 0.5× 157 0.4× 51 2.3k
Constantinos M. Mikelis United States 26 1.3k 1.1× 415 0.7× 297 0.6× 142 0.3× 453 1.2× 75 2.2k
Yu Guo China 28 1.1k 1.0× 636 1.0× 335 0.7× 427 0.9× 423 1.2× 91 2.3k
Huafeng Zhang China 17 609 0.5× 335 0.5× 259 0.5× 288 0.6× 319 0.9× 30 1.3k
Shengyong Yin China 27 1.3k 1.1× 603 1.0× 547 1.1× 272 0.6× 879 2.4× 78 2.7k
Danilo Marimpietri Italy 30 1.5k 1.3× 459 0.7× 412 0.8× 293 0.6× 578 1.6× 67 2.6k

Countries citing papers authored by Pingwei Xu

Since Specialization
Citations

This map shows the geographic impact of Pingwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingwei Xu more than expected).

Fields of papers citing papers by Pingwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingwei Xu. The network helps show where Pingwei Xu may publish in the future.

Co-authorship network of co-authors of Pingwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Pingwei Xu. A scholar is included among the top collaborators of Pingwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingwei Xu. Pingwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Weiwei, Pingwei Xu, Sheng Guo, et al.. (2023). Application of tumor microparticles in tumor prevention and treatment. Cancer Nanotechnology. 14(1). 2 indexed citations
2.
Liu, Jing, Youhua Tan, Huafeng Zhang, et al.. (2021). Author Correction: Soft fibrin gels promote selection and growth of tumorigenic cells. Nature Materials. 20(6). 905–905. 4 indexed citations
3.
Gao, Yunfeng, Hui Zhang, Nannan Zhou, et al.. (2020). Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma. Nature Biomedical Engineering. 4(7). 743–753. 117 indexed citations
4.
Ma, Jingwei, Keke Wei, Junwei Liu, et al.. (2020). Glycogen metabolism regulates macrophage-mediated acute inflammatory responses. Nature Communications. 11(1). 1769–1769. 157 indexed citations
5.
Tang, Ke, Yuandong Yu, Liyan Zhu, et al.. (2019). Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells. Oncogene. 38(44). 6970–6984. 48 indexed citations
6.
Zhang, Huafeng, Ke Tang, Jingwei Ma, et al.. (2019). Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development. Nature Cell Biology. 22(1). 18–25. 138 indexed citations
7.
Chen, Jie, Weiwei Sun, Huafeng Zhang, et al.. (2019). Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β. Cellular and Molecular Immunology. 17(12). 1233–1244. 55 indexed citations
8.
Ma, Jingwei, Keke Wei, Huafeng Zhang, et al.. (2018). Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells. Cancer Immunology Research. 6(9). 1057–1068. 64 indexed citations
9.
Zhang, Huafeng, Yuandong Yu, Li Zhou, et al.. (2018). Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent Pathway. Cancer Immunology Research. 6(9). 1046–1056. 48 indexed citations
10.
Ma, Ruihua, Tiantian Ji, Yi Zhang, et al.. (2017). A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells. Nature Cell Biology. 20(1). 21–27. 151 indexed citations
11.
Sun, Yanling, Huafeng Zhang, Yuandong Yu, et al.. (2017). Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway. OncoImmunology. 6(6). e1309487–e1309487. 29 indexed citations
12.
Jin, Xun, Jingwei Ma, Xiaoyu Liang, et al.. (2016). Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway. Biomaterials. 113. 93–104. 29 indexed citations
13.
Li, Yong, Shunqun Luo, Ruihua Ma, et al.. (2015). Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors. Cancer Research. 75(7). 1191–1196. 68 indexed citations
14.
Ma, Ruihua, Wanguang Zhang, Ke Tang, et al.. (2013). Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nature Communications. 4(1). 2508–2508. 132 indexed citations
15.
Li, Dapeng, Wenqian Cai, Runxia Gu, et al.. (2013). Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients. Clinical Immunology. 149(3). 411–420. 101 indexed citations
16.
Zhang, Yi, Ruihua Zhang, Huafeng Zhang, et al.. (2012). Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity. Cellular and Molecular Immunology. 9(6). 489–496. 22 indexed citations
17.
Liu, Jing, Youhua Tan, Huafeng Zhang, et al.. (2012). Soft fibrin gels promote selection and growth of tumorigenic cells. Nature Materials. 11(8). 734–741. 384 indexed citations
18.
Yuan, Bo, et al.. (2012). Role of Metabolism in the Effects of Genistein and Its Phase II Conjugates on the Growth of Human Breast Cell Lines. The AAPS Journal. 14(2). 329–344. 30 indexed citations
19.
Tang, Ke, Yi Zhang, Huafeng Zhang, et al.. (2012). Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nature Communications. 3(1). 1282–1282. 398 indexed citations
20.
Yuan, Bo, et al.. (2010). Validated HPLC method for the quantitative determination of CoQ10 in dog plasma and its application to a pharmacokinetic study. Biomedical Chromatography. 25(9). 1038–1044. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingwei Ma Breakdown of academic impact, for papers by Simon Tazzyman Breakdown of academic impact, for papers by Hongwei Lv Breakdown of academic impact, for papers by Jing Song Breakdown of academic impact, for papers by Leni Moldovan Breakdown of academic impact, for papers by Constantinos M. Mikelis Breakdown of academic impact, for papers by Yu Guo Breakdown of academic impact, for papers by Huafeng Zhang Breakdown of academic impact, for papers by Shengyong Yin Breakdown of academic impact, for papers by Danilo Marimpietri
Rankless by CCL
2026